Price $21.08 |
Market Cap
2.88B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
14.2
|
P/B
2.68
|
P/S
0.46
|
Dividend %
3.30%
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-705.7K
|
FCF
-8.9
|
|
Op. Margin
4.30%
|
Net Margin
3.30%
|
ROE
19.60%
|
ROI
12.90%
|
|
ROA
7.40%
|
EPS Growth
11.00%
|
Current Ratio
1.6
|
Debt/Equity
40.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc (INM) | $0.27 | - | - | 1.6M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $15.72 | - | - | 1.19B | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
